USANA Health Sciences, Inc. (USNA) is a Packaged Foods company in the Consumer Defensive sector, currently trading at $18.51. It has a SharesGrow Score of 64/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of USNA = $104.87 (+466.6% from the current price, the stock appears undervalued). Analyst consensus target is USNA = $35 (+89.1% upside).
Valuation: USNA trades at a trailing Price-to-Earnings (P/E) of 30.1 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.78.
Financials: revenue is $925M, +0.4%/yr average growth. Net income is $11M, growing at -36.2%/yr. Net profit margin is 1.2% (thin). Gross margin is 78.3% (-2.5 pp trend).
Balance sheet: total debt is $14M against $533M equity (Debt-to-Equity (D/E) ratio 0.03, conservative). Current ratio is 2.24 (strong liquidity). Debt-to-assets is 1.9%. Total assets: $743M.
Analyst outlook: 2 / 8 analysts rate USNA as buy (25%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 90/100 (Pass), Growth 30/100 (Fail), Past 100/100 (Pass), Health 100/100 (Pass), Moat 49/100 (Partial), Future 52/100 (Partial), Income 30/100 (Fail).
